Tango Therapeutics, Inc.
Tango Therapeutics, Inc. (TNGX) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 82 transactions totaling $80.8M, demonstrating a bearish sentiment with -$37.5M in net insider flow. The most recent transaction on Jan 8, 2026 involved a transaction of 1,650,000 shares valued at $0.
TNGX Insider Activity Summary
Who Is Buying TNGX Stock?
No significant insider buying has been recorded for TNGX in the recent period.
Who Is Selling TNGX Stock?
No significant insider selling has been recorded for TNGX in the recent period.
Is Tango Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TNGX is bearish with an Insider Alignment Score of 27/100 and a net flow of -$37.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
TNGX Frequently Asked Questions
Understanding TNGX Insider Activity
Insider trading at Tango Therapeutics, Inc. (TNGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading TNGX stock, having executed 82 transactions in the past 90 days. The most active insider is Rock Ventures Gp Iv, L.p. Third (Executive), who has made 10 transactions totaling $24.2M.
Related Tools
Track Tango Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TNGX file new Form 4 transactions